drugset / Trial / NCT07692256
the Clinical Outcome of Empagliflozin in Pediatric Heart Failure Patients
RandomizedParallel-groupTriple-blindTreatment
Summary
the study to investigate the efficacy of empagiflozin in pediatric heart failure
Timeline
- Start
- 2025-12-01
- Primary completion
- 2026-12-01
- Completion
- 2027-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Empagliflozin | Small molecule | 0.25 mg/kg | Other |
| Subject | Empagliflozin | Small molecule | 0.5 mg/kg | Other |